<?xml version="1.0" encoding="UTF-8"?><lom xmlns="http://ltsc.ieee.org/xsd/LOM" xmlns:lomfr="http://www.lom-fr.fr/xsd/LOMFR" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://ltsc.ieee.org/xsd/LOM http://www.lom-fr.fr/xsd/lomfrv1.0/std/lomfr.xsd">
<general>
<identifier>
<catalog>Canal-U_Ocms</catalog>
<entry>3845</entry>
</identifier>
<title><string language="fre"><![CDATA[Treatment of dunning R3327 prostatic adenocarcinoma in rats by ablatherm]]></string></title>
<language>ENG</language>
<description>
<string language="fre"><![CDATA[The experimental Dunning R 3327 prostatic adenocarcinoma is developped in Fisher/Copenhague hybrid rats. The Mat-Ly Lu subline is the most agressive : approximately 20 days after subcutaneous inoculation, the animal presents a large tumor associated with multiple metastases which provoke death. The ablatherm is an extracorporal treatment device which generates high energy focused ultrasounds. It is made up of a shot device (which includes a 7,5 KW amplifier, a pulse generator, a frequency generator and a 1 MHz transducer), a localization device (which includes a strereotaxic arm and an ultrasound) and a computer for both shots and device movements control. The dunning tumors are irradited 5 to 7 days after inoculation. Focused ultrasound absobtion by the tumor leads to partial or total destruction of the tumor by a mechanism which associates hyperthermia and cavitation. In rats treated with success (total destruction to the tumour), we can see a progressive disappearance of the tumor with no local recurrence. Some animals develop distant metastases but others show a long term survival with to local recurrence. Some animals develop distant metastases but others show a long term survival with no detectable metastases. In certain conditions, the Ablatherm could destruct the Dunning R 3327 May-Ly Lu adenocarcinoma and il could also cure the animal whith no adjuvant therapy.
FILMED_92_5204_469
1992]]></string></description>
<keyword><string language="fre"><![CDATA[FILMED]]></string></keyword><keyword><string language="fre"><![CDATA[ablatherm]]></string></keyword><keyword><string language="fre"><![CDATA[Dunning R3327]]></string></keyword><keyword><string language="fre"><![CDATA[prostatic adenocarcinoma]]></string></keyword>
<lomfr:documentType>
<lomfr:source>LOMFRv1.0</lomfr:source>
<lomfr:value>image en mouvement</lomfr:value>
</lomfr:documentType>
</general><lifeCycle>
<contribute>
<role>
<source>LOMv1.0</source>
<value>author</value>
</role>
<entity><![CDATA[BEGIN:VCARD
VERSION:3.0
CLASS:PUBLIC
REV:2022-04-04 18:08:53
FN:Albert GELET
N:GELET;Albert;;;
URL;TYPE=work:https://www.canal-u.tv/auteurs/gelet_albert
ROLE:author
NOTE: Statut PH Spécialités Urologie 
TZ:+0200
END:VCARD
]]></entity>
<date><dateTime>1992-01-01</dateTime></date>
</contribute>
<contribute>
<role>
<source>LOMv1.0</source>
<value>author</value>
</role>
<entity><![CDATA[BEGIN:VCARD
VERSION:3.0
CLASS:PUBLIC
REV:2022-04-04 18:08:53
FN:J. MARGORANI
N:MARGORANI;J.;;;
URL;TYPE=work:https://www.canal-u.tv/auteurs/margorani_j
ROLE:author
TZ:+0200
END:VCARD
]]></entity>
<date><dateTime>1992-01-01</dateTime></date>
</contribute>
<contribute>
<role>
<source>LOMv1.0</source>
<value>author</value>
</role>
<entity><![CDATA[BEGIN:VCARD
VERSION:3.0
CLASS:PUBLIC
REV:2022-04-04 18:08:53
FN:J. CHAPELON
N:CHAPELON;J.;;;
URL;TYPE=work:https://www.canal-u.tv/auteurs/chapelon_j
ROLE:author
TZ:+0200
END:VCARD
]]></entity>
<date><dateTime>1992-01-01</dateTime></date>
</contribute>
<contribute>
<role>
<source>LOMv1.0</source>
<value>author</value>
</role>
<entity><![CDATA[BEGIN:VCARD
VERSION:3.0
CLASS:PUBLIC
REV:2022-04-04 18:08:53
FN:D. CATHIGOL
N:CATHIGOL;D.;;;
URL;TYPE=work:https://www.canal-u.tv/auteurs/cathigol_d
ROLE:author
TZ:+0200
END:VCARD
]]></entity>
<date><dateTime>1992-01-01</dateTime></date>
</contribute>
<contribute>
<role>
<source>LOMv1.0</source>
<value>content provider</value>
</role>
<entity><![CDATA[BEGIN:VCARD
VERSION:3.0
CLASS:PUBLIC
REV:2022-04-04 18:08:53
FN:FILMED
N:FILMED;;;;
URL;TYPE=work:https://www.canal-u.tv/auteurs/filmed
ROLE:content provider
NOTE:Vidéothèque FILMED Faculté de Médecine 3, rue des Louvels 80 036 AMIENS Cedex1 
TZ:+0200
END:VCARD
]]></entity>
<date><dateTime>1992-01-01</dateTime></date>
</contribute>
</lifeCycle>
<metaMetadata>
<metadataSchema>LOMv1.0</metadataSchema>
<metadataSchema>LOMFRv1.0</metadataSchema>
</metaMetadata>
<technical>
<format>video/mp4</format>
<location><![CDATA[https://www.canal-u.tv/video/canal_u_medecine/treatment_of_dunning_r3327_prostatic_adenocarcinoma_in_rats_by_ablatherm.3845]]></location>
<location><![CDATA[https://streaming-canal-u.fmsh.fr/vod/media/canalu/videos/cutms/treatment.of.dunning.r3327.prostatic.adenocarcinoma.in.rats.by.ablatherm_3845/treatment_of_dunning_r3327_prostatic_adenocarcinoma_in_rats_by_ablatherm.sd.mp4]]></location>
<size>34733802</size>
<duration><duration>PT0H9M52S</duration></duration>
</technical>
<educational>
<learningResourceType>
<source>LOMv1.0</source>
<value>lecture</value>
</learningResourceType>
<context>
<source>LOMv1.0</source>
<value>formation continue</value>
</context>
<context>
<source>LOMv1.0</source>
<value>higher education</value>
</context>
</educational>
<rights>
<cost>
<source>LOMv1.0</source>
<value>no</value>
</cost>
<copyrightAndOtherRestrictions>
<source>LOMv1.0</source>
<value>no</value>
</copyrightAndOtherRestrictions>
<description>
<string language="fre"><![CDATA[Droits réservés à l'éditeur et aux auteurs. 
]]></string>
</description>
</rights>
<relation>
<kind>
<source>LOMv1.0</source>
<value>ispartof</value>
</kind>
<resource>
<identifier>
<catalog>URI</catalog>
<entry>https://www.canal-u.tv/producteurs/canal_u_medecine/urologie/film</entry>
</identifier>
<description>
<string language="fre"><![CDATA[Film.]]></string>
</description>
</resource>
</relation>
<classification>
<purpose>
<source>LOMv1.0</source>
<value>discipline</value>
</purpose>
<taxonPath>
<source>
<string language="fre"><![CDATA[Universités Numériques Thématiques 2009 http://www.universites-numeriques.fr]]></string>
</source>
<taxon>
<id/>
<entry>
<string language="fre"/>
</entry>
</taxon>
</taxonPath>
</classification>
<classification>
<purpose>
<source>LOMv1.0</source>
<value>discipline</value>
</purpose>
<taxonPath>
<source>
<string language="fre">CDD 22e éd.</string>
<string language="eng">DDC 22nd ed.</string>
</source>
<taxon>
<id>610</id>
<entry>
<string language="fre"><![CDATA[Sciences médicales. Médecine]]></string>
</entry>
</taxon>
</taxonPath>
</classification> </lom>